Renaissance Technologies - VALEANT PHARMACEUTICALS INTL ownership

VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 560 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2015. The put-call ratio across all filers is 2.18 and the average weighting 1.4%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of VALEANT PHARMACEUTICALS INTL
ValueSharesWeighting
Q2 2018$174,348,000
+120.1%
9,069,278
+82.3%
0.10%
+9.2%
Q1 2018$79,213,000
-64.2%
4,975,689
-53.3%
0.09%
-64.3%
Q4 2017$221,332,000
+223.1%
10,651,189
+122.8%
0.24%
+201.2%
Q3 2017$68,505,000
+64.8%
4,780,500
+99.0%
0.08%
+52.8%
Q2 2017$41,574,000
-1.7%
2,402,589
-17.5%
0.05%
-20.9%
Q4 2016$42,294,000
+298.3%
2,913,089
+573.6%
0.07%
+252.6%
Q3 2016$10,618,000
+371.3%
432,489
+286.5%
0.02%
+375.0%
Q2 2016$2,253,000
-90.6%
111,889
+3.8%
0.00%
-92.7%
Q2 2015$23,942,000
-74.7%
107,789
-77.3%
0.06%
-72.6%
Q1 2015$94,465,000
+1592.9%
475,837
+1120.4%
0.20%
+1446.2%
Q4 2014$5,580,000
-10.3%
38,989
-17.4%
0.01%
-13.3%
Q1 2014$6,218,000
-85.5%
47,189
-87.0%
0.02%
-85.3%
Q4 2013$42,756,000364,1890.10%
Other shareholders
VALEANT PHARMACEUTICALS INTL shareholders Q1 2015
NameSharesValueWeighting ↓
Bruce & Co., Inc. 850,000$6,987,0002.38%
View complete list of VALEANT PHARMACEUTICALS INTL shareholders